loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for r0_cep_2021_277___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MEGAFINE PHARMA (P) LIMITED Mumbai IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMegafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.

R0-CEP 2021-277 - Rev 01
Valid
Chemical
2023-08-07
2932
Megafine Pharma

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMegafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.

Certificate Number : R0-CEP 2021-277 - Rev 01

Status : Valid

Issue Date : 2023-08-07

Type : Chemical

Substance Number : 2932

Megafine Pharma

Looking for Certificates of Suitability (CEPs) for R0-CEP 2021-277 - Rev 01 of Megafine Pharma (p) Limited Mumbai In

Looking for Certificates of Suitability (CEPs) for R0-CEP 2021-277 - Rev 01 of Megafine Pharma (p) Limited Mumbai In 1

20

Megafine Pharma (p) Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.

One of their significant offerings is Rivaroxaban, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-277 - Rev 01

This Chemical Type CEP, issued on August 07, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2932 associated with this CEP further emphasizes